Conserved responses to trichostatin A in rodent lungs exposed to endotoxin or stretch

Pulmonary Pharmacology and Therapeutics

Volumn 22, Issue 6, 2009, Pages 593-602

  Dombrowsky, Heike ^a   Barrenschee, Martina ^b   Kunze, Maren ^a   Uhlig, Stefan ^b  

^a RESEARCH CENTER BORSTEL   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Biotrauma; Gene transcription; HDAC; Lipopolysaccharide; Mechanical ventilation; Steroids

Indexed keywords

CXCL2 CHEMOKINE; DEXAMETHASONE; ENDOTOXIN; HISTONE; INTERLEUKIN 6; TRICHOSTATIN A; TUMOR NECROSIS FACTOR;

ACETYLATION; ANIMAL TISSUE; ARTICLE; DOWN REGULATION; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; LUNG RESISTANCE; MECHANICAL STRESS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; STIMULUS RESPONSE; TIDAL VOLUME; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CYTOKINES; DNA PRIMERS; ENDOTOXINS; GENE EXPRESSION; HISTONE DEACETYLASE INHIBITORS; HISTONES; HYDROXAMIC ACIDS; LUNG; LUNG COMPLIANCE; LUNG DISEASES; MALE; MICE; MICE, INBRED BALB C; RATS; RESPIRATION, ARTIFICIAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STARCH; TIDAL VOLUME;

EID: 71249163430     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2009.08.005     Document Type: Article

References (45)

1. Ito K., Charron C.E., and Adcock I.M. Impact of protein acetylation in inflammatory lung diseases. Pharmacol Ther 116 (2007) 249-265
2. Schrump D.S., and Nguyen D.M. Targeting the epigenome for the treatment of thoracic malignancies. Thorac Surg Clin 16 (2006) 367-377
3. Bhavsar P., Ahmad T., and Adcock I.M. The role of histone deacetylases in asthma and allergic diseases. J Allergy Clin Immunol 121 (2008) 580-584
4. Adcock I.M. Histone deacetylase inhibitors as novel anti-inflammatory agents. Curr Opin Investig Drugs 7 (2006) 966-973
5. Adcock I.M., Ito K., and Barnes P.J. Histone deacetylation: an important mechanism in inflammatory lung diseases. COPD 2 (2005) 445-455
6. Ito K., Barnes P.J., and Adcock I.M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1β-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 20 (2000) 6891-6903
7. Ito K., Ito M., Elliott W.M., Cosio B., Caramori G., Kon O.M., et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352 (2005) 1967-1976
8. Cosio B.G., Mann B., Ito K., Jazrawi E., Barnes P.J., Chung K.F., et al. Histone acetylase and deacetylase activity in alveolar macrophages and blood monocytes in asthma. Am J Respir Crit Care Med 170 (2004) 141-147
9. Barnes P.J. Corticosteroid effects on cell signalling. Eur Respir J 27 (2006) 413-426
10. Dombrowsky H., and Uhlig S. Steroids and histone deacetylase in ventilation-induced gene transcription. Eur Respir J 30 (2007) 865-877
11. Iwata K., Tomita K., Sano H., Fujii Y., Yamasaki A., and Shimizu E. Trichostatin A, a histone deacetylase inhibitor, down-regulates interleukin-12 transcription in SV-40-transformed lung epithelial cells. Cell Immunol 218 (2002) 26-33
12. Keslacy S., Tliba O., Baidouri H., and Amrani Y. Inhibition of tumor necrosis factor-alpha-inducible inflammatory genes by interferon-γ is associated with altered nuclear factor-κ transactivation and enhanced histone deacetylase activity. Mol Pharmacol 71 (2007) 609-618
13. Gilmour P.S., Rahman I., Donaldson K., and MacNee W. Histone acetylation regulates epithelial IL-8 release mediated by oxidative stress from environmental particles. Am J Physiol Lung Cell Mol Physiol 284 (2003) L533-L540
14. Schmeck B., Lorenz J., N'Guessan P.D., Opitz B., van L.V., Zahlten J., et al. Histone acetylation and flagellin are essential for Legionella pneumophila-induced cytokine expression. J Immunol 181 (2008) 940-947
15. Slevogt H., Schmeck B., Jonatat C., Zahlten J., Beermann W., van L.V., et al. Moraxella catarrhalis induces inflammatory response of bronchial epithelial cells via MAPK and NF-κB activation and histone deacetylase activity reduction. Am J Physiol Lung Cell Mol Physiol 290 (2006) L818-L826
16. Tomita K., Barnes P.J., and Adcock I.M. The effect of oxidative stress on histone acetylation and IL-8 release. Biochem Biophys Res Commun 301 (2003) 572-577
17. Kagoshima M., Wilcke T., Ito K., Tsaprouni L., Barnes P.J., Punchard N., et al. Glucocorticoid-mediated transrepression is regulated by histone acetylation and DNA methylation. Eur J Pharmacol 429 (2001) 327-334
18. Lee K.Y., Ito K., Hayashi R., Jazrawi E.P., Barnes P.J., and Adcock I.M. NF-κB and activator protein 1 response elements and the role of histone modifications in IL-1β-induced TGF-β1 gene transcription. J Immunol 176 (2006) 603-615
19. Imre G., Gekeler V., Leja A., Beckers T., and Boehm M. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-κB by tumor necrosis factor-α receptor-1 down-regulation. Cancer Res 66 (2006) 5409-5418
20. Choi J.H., Oh S.W., Kang M.S., Kwon H.J., Oh G.T., and Kim D.Y. Trichostatin A attenuates airway inflammation in mouse asthma model. Clin Exp Allergy 35 (2005) 89-96
21. Leoni F., Zaliani A., Bertolini G., Porro G., Pagani P., Pozzi P., et al. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc Natl Acad Sci USA 99 (2002) 2995-3000
22. Lin H.S., Hu C.Y., Chan H.Y., Liew Y.Y., Huang H.P., Lepescheux L., et al. Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents. Br J Pharmacol 150 (2007) 862-872
23. Uhlig S., and Uhlig U. Pharmacological interventions in ventilator-induced lung injury. Trends Pharmacol Sci 25 (2004) 592-600
24. von Bethmann A.N., Brasch F., Nüsing R., Vogt K., Volk D., Müller K.M., et al. Hyperventilation induces release of cytokines from perfused mouse lung. Am J Respir Crit Care Med 157 (1998) 263-272
25. Uhlig S., and Wollin L. An improved setup for the isolated perfused rat lung. J Pharm Tox Meth 31 (1994) 85-94
26. Uhlig S., Brasch F., Wollin L., Fehrenbach H., Richter J., and Wendel A. Functional and fine structural changes in isolated rat lungs challenged with endotoxin ex vivo and in vitro. Am J Pathol 146 (1995) 1235-1247
27. Opal SM. The value of animal models in endotoxin research. In Endotoxin in Health and Disease; Eds. Brade H, Opal SM, Vogel SN, Morrison DC. Marcel Dekker 1999;809-16.
28. Uhlig U., Drömann D., Goldmann T., Dombrowsky H., Vollmer E., Zabel P., et al. Pulmonary responses to overventilation in late multiple organ failure. Anesthesiology 105 (2006) 1192-1200
29. Ito K., and Adcock I.M. Histone acetylation and histone deacetylation. Mol Biotechnol 20 (2002) 99-106
30. Litell R.C., Milliken G.A., Stroup W.W., Wolfinger R.D., and Schabenberger O. SAS for mixed models. 2nd ed. (2006), SAS Inst. Inc., Cary, NC
31. Held H.D., Boettcher S., Hamann L., and Uhlig S. Ventilation-induced chemokine and cytokine release is associated with activation of NF-κB and is blocked by steroids. Am J Respir Crit Care Med 163 (2001) 711-716
32. Dolinay T., Kaminski N., Felgendreher M., Kim H.P., Reynolds P., Watkins S.C., et al. Gene expression profiling of target genes in ventilator-induced lung injury. Physiol Genom 26 (2006) 68-75
33. Meier T., Lange A., Papenberg H., Ziemann M., Fentrop C., Uhlig U., et al. Pulmonary cytokine responses during mechanical ventilation of non-injured lungs with and without end-expiratory pressure. Anesth Analog 107 (2008) 1265-1275
34. Van L.C., Emiliani S., and Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr 5 (1996) 245-253
35. Lee H., Lee S., Baek M., Kim H.-Y., and Jeoung D.J. Expression profile analysis of trichostatin A in human gastric cancer cells. Biotech Lett 24 (2002) 377-381
36. Isowa N., Keshavjee S.H., and Liu M. Role of microtubules in LPS-induced macrophage inflammatory protein-2 production from rat pneumocytes. Am J Physiol Lung Cell Mol Physiol 279 (2000) L1075-L1082
37. Siavoshian S., Segain J.P., Kornprobst M., Bonnet C., Cherbut C., Galmiche J.P., et al. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut 46 (2000) 507-514
38. Nasu Y., Nishida K., Miyazawa S., Komiyama T., Kadota Y., Abe N., et al. Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model. Osteoarth Cartil 16 (2008) 723-732
39. Camelo S., Iglesias A.H., Hwang D., Due B., Ryu H., Smith K., et al. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J Neuroimmunol 164 (2005) 10-21
40. Glauben R., Batra A., Fedke I., Zeitz M., Lehr H.A., Leoni F., et al. Histone hyperacetylation is associated with amelioration of experimental colitis in mice. J Immunol 176 (2006) 5015-5022
41. Wang Z., Zang C., Rosenfeld J.A., Schones D.E., Barski A., Cuddapah S., et al. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40 (2008) 897-903
42. Ahn K.S., and Aggarwal B.B. Transcription factor NF-κB: a sensor for smoke and stress signals. Ann N Y Acad Sci 1056 (2005) 218-233
43. Nissen R.M., and Yamamoto K.R. The glucocorticoid receptor inhibits NF-κB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev 14 (2000) 2314-2329
44. Mishra N., Reilly C.M., Brown D.R., Ruiz P., and Gilkeson G.S. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J Clin Invest 111 (2003) 539-552
45. Choo Q.Y., Ho P.C., and Lin H.S. Histone deacetylase inhibitors: new hope for rheumatoid arthritis?. Curr Pharm Des 14 (2008) 803-820